IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Works in Oncology
IDRX, Inc., a wholly owned subsidiary of GSK, LLC is a clinical trial sponsor. It has 1 active clinical trial with 276 planned participants, in Oncology.
Trial track record · since 2021
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about IDRX, Inc., a wholly owned subsidiary of GSK, LLC
IDRX, Inc., a wholly owned subsidiary of GSK, LLC is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 276 planned participants, in Oncology. Since 2021 it has completed 0 trials and stopped 0 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with IDRX, Inc., a wholly owned subsidiary of GSK, LLC; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-05.
Approve Suite is not affiliated with IDRX, Inc., a wholly owned subsidiary of GSK, LLC.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.